Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI

Quick Summary:

Aqemia, a French startup that’s meshing “quantum-inspired physics” with machine learning to find new drugs, has raised $38 million in a fresh round of funding led by San Francisco-based VC firm Cathay Innovation.

It’s clear that AI-enabled drug discovery is a hot space right now, and Aqemia itself has already been making headway in industry.

Last December, the startup signed a multi-year agreement with French pharmaceutical giant Sanofi, a deal that could be worth up to $140 million depending on the outcome of certain R&D milestones.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Paul Sawers

Category: Technology

Markets: United StatesFrance

Topics: Drug discovery AI Aqemia

Source Website Secure: Yes (HTTPS)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-10 @ 11:13:48 (2 days ago)

News Timezone: GMT -5:00

News Source URL: techcrunch.com

Language: English

Article Length: 563 words

Reading Time: 4 minutes read

Sentences: 16 lines

Sentence Length: 36 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © TechCrunch

News ID: 24322080

View Article Analysis

About TechCrunch

Main Topics: Technology

Official Website: techcrunch.com

Update Frequency: 30 posts per day

Year Established: 2005

Headquarters: United States

News Last Updated: 8 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #20

Publisher Details

Frequently Asked Questions